Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-specific Neoantigen Peptide-HLA Complex (pHLA)
- Target
- pHLA
- Molecular classification
- Complex, Peptide-MHC Complex, Antigen presentation complex
01
Overview
Tumor-specific neoantigen peptide-HLA complexes are formed when mutated peptides derived from tumor cells are presented on the cell surface by human leukocyte antigen (HLA) molecules. These complexes serve as targets for T cell recognition and cancer immunotherapy. They play a crucial role in signaling the presence of cancerous cells to the immune system, leading to T cell activation and tumor rejection. Targeting these complexes is a promising avenue for personalized cancer immunotherapy.
- Other names
- Neoantigen-HLA ComplexTumor-specific antigen presentationMutated peptide-HLA complex
02
Mechanism of action
Presentation of tumor-specific mutated peptides to T cells, leading to T cell activation and tumor cell lysis.
03
Biological functions
Antigen presentationT cell activationImmune recognitionTumor rejectionAdaptive immunity
04
Disease associations
CancerImmune evasionTarget for immunotherapy
05
Safety considerations
Off-target effectsAutoimmunityCytokine release syndromeTumor heterogeneityLow expression levels
06
Interacting drugs
Neoantigen vaccines
3 more in the full profile.
07
Biomarkers
Neoantigen expressionHLA typeT cell infiltrationTCR repertoireMutational burden
Beyond the preview
Go deeper on Tumor-specific Neoantigen Peptide-HLA Complex (pHLA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor-specific Neoantigen Peptide-HLA Complex (pHLA).